Huadong Medicine Co Ltd - Asset Resilience Ratio

Latest as of June 2024: 0.05%

Huadong Medicine Co Ltd (000963) has an Asset Resilience Ratio of 0.05% as of June 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check 000963 capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets

CN¥16.49 Million

≈ $2.41 Million USD Cash + Short-term Investments

Total Assets

CN¥36.17 Billion

≈ $5.29 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2000–2017)

This chart shows how Huadong Medicine Co Ltd's Asset Resilience Ratio has changed over time. See Huadong Medicine Co Ltd net asset quality index to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Huadong Medicine Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Huadong Medicine Co Ltd (000963) market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥16.49 Million	0.05%
Total Liquid Assets	CN¥16.49 Million	0.05%

Asset Resilience Insights

Limited Liquidity: Huadong Medicine Co Ltd maintains only 0.05% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Huadong Medicine Co Ltd Industry Peers by Asset Resilience Ratio

Compare Huadong Medicine Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Aurobindo Pharma Limited NSE:AUROPHARMA	Drug Manufacturers - Specialty & Generic	1.28%
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	Drug Manufacturers - Specialty & Generic	11.60%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Tianjin Chase Sun Pharmaceutical Co Ltd SHE:300026	Drug Manufacturers - Specialty & Generic	-0.89%
Zhejiang Hisoar Pharmaceutical Co Ltd SHE:002099	Drug Manufacturers - Specialty & Generic	0.20%
Xeris Pharmaceuticals Inc NASDAQ:XERS	Drug Manufacturers - Specialty & Generic	0.00%
Procter & Gamble Health Limited NSE:PGHL	Drug Manufacturers - Specialty & Generic	33.01%

Annual Asset Resilience Ratio for Huadong Medicine Co Ltd (2000–2017)

The table below shows the annual Asset Resilience Ratio data for Huadong Medicine Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2017-12-31	4.25%	CN¥680.00 Million ≈ $99.51 Million	CN¥15.99 Billion ≈ $2.34 Billion	+3.22pp
2016-12-31	1.04%	CN¥150.00 Million ≈ $21.95 Million	CN¥14.46 Billion ≈ $2.12 Billion	+1.01pp
2014-12-31	0.03%	CN¥2.50 Million ≈ $365.83K	CN¥9.01 Billion ≈ $1.32 Billion	-0.79pp
2005-12-31	0.82%	CN¥16.86 Million ≈ $2.47 Million	CN¥2.05 Billion ≈ $300.54 Million	-0.13pp
2004-12-31	0.95%	CN¥16.86 Million ≈ $2.47 Million	CN¥1.77 Billion ≈ $258.79 Million	+0.91pp
2003-12-31	0.05%	CN¥661.00K ≈ $96.73K	CN¥1.43 Billion ≈ $209.98 Million	-9.11pp
2000-12-31	9.16%	CN¥104.74 Million ≈ $15.33 Million	CN¥1.14 Billion ≈ $167.32 Million	--

pp = percentage points

About Huadong Medicine Co Ltd

SHE:000963 China Drug Manufacturers - Specialty & Generic

Market Cap

$7.25 Billion

CN¥49.57 Billion CNY

Market Cap Rank

#2850 Global

#376 in China

Share Price

CN¥28.26

Change (1 day)

-2.55%

52-Week Range

CN¥27.69 - CN¥46.17

All Time High

CN¥96.84